LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

Search

Neogen Corp

Закрыт

СекторЗдравоохранение

11.1 -2.03

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

11.03

Макс.

11.33

Ключевые показатели

By Trading Economics

Доход

-52M

-16M

Продажи

16M

225M

Рентабельность продаж

-7.087

Сотрудники

2,974

EBITDA

-66M

23M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

-5.83% downside

Дивиденды

By Dow Jones

Следующий отчет о доходах

8 апр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

802M

2.4B

Предыдущая цена открытия

13.13

Предыдущая цена закрытия

11.1

Новостные настроения

By Acuity

50%

50%

149 / 351 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Strong Bullish Evidence

Neogen Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

23 февр. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Keurig Dr Pepper Raises Additional $1.5 Billion in Deal to Split Company

23 февр. 2026 г., 22:36 UTC

Отчет

Kratos Defense & Security Solutions 4Q Profit Rises; Sees Federal Shutdown Denting 1Q -- Update

23 февр. 2026 г., 22:32 UTC

Отчет

Woodside Energy Fiscal Year Net Profit Falls 24%

23 февр. 2026 г., 23:58 UTC

Обсуждения рынка
Отчет

Plenty of Questions for Woodside Despite Well-Guided Result -- Market Talk

23 февр. 2026 г., 23:58 UTC

Обсуждения рынка
Отчет

Global Energy Roundup: Market Talk

23 февр. 2026 г., 23:47 UTC

Обсуждения рынка

Scentre's Share Price Slips as Earnings Guidance Underwhelms -- Market Talk

23 февр. 2026 г., 23:43 UTC

Обсуждения рынка

Gold Edges Higher Amid Ongoing Tariff Risks -- Market Talk

23 февр. 2026 г., 23:41 UTC

Приобретения, слияния, поглощения

Crescent Capital Partners Owns 53% of ClearView Wealth

23 февр. 2026 г., 23:40 UTC

Приобретения, слияния, поглощения

ClearView Wealth Says Crescent Capital Partners Intends to Support Deal

23 февр. 2026 г., 23:40 UTC

Приобретения, слияния, поглощения

ClearView Wealth Says Directors Unanimously Recommend Shareholders Vote in Favor of Deal

23 февр. 2026 г., 23:40 UTC

Обсуждения рынка

Nikkei May Rise as Investors Assess Tariff Developments -- Market Talk

23 февр. 2026 г., 23:40 UTC

Приобретения, слияния, поглощения

ClearView Wealth Says Zurich Insurance Offering A$0.65/Share in Cash

23 февр. 2026 г., 23:39 UTC

Приобретения, слияния, поглощения

ClearView Wealth Agrees to Takeover by Zurich Insurance Group Unit

23 февр. 2026 г., 23:31 UTC

Отчет

United Overseas Bank 2025 Total Dividend S$1.56/Shr >U11.SG

23 февр. 2026 г., 23:31 UTC

Отчет

United Overseas Bank Proposes Final Dividend of S$0.71/Shr Vs. S$0.92/Shr >U11.SG

23 февр. 2026 г., 23:28 UTC

Отчет

United Overseas Bank 4Q Net Interest Income S$2.35B Vs. S$2.45B >U11.SG

23 февр. 2026 г., 23:28 UTC

Отчет

United Overseas Bank 4Q Oper Pft S$1.76B Vs. Pft S$1.88B >U11.SG

23 февр. 2026 г., 23:28 UTC

Отчет

United Overseas Bank 4Q Total Income S$3.29B Vs. S$3.46B >U11.SG

23 февр. 2026 г., 23:27 UTC

Отчет

United Overseas Bank 4Q Net S$1.41B Vs. Net S$1.52B >U11.SG

23 февр. 2026 г., 23:24 UTC

Обсуждения рынка

Major Miners On Whole Delivered Positive Earnings Season -- Market Talk

23 февр. 2026 г., 22:38 UTC

Приобретения, слияния, поглощения

Keurig Dr Pepper Raises Additional $1.5B in Deal to Split Company

23 февр. 2026 г., 22:31 UTC

Отчет

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. -- Barrons.com

23 февр. 2026 г., 22:24 UTC

Отчет

Viva Energy Energy & Infrastructure Ebitda A$93 Million

23 февр. 2026 г., 22:22 UTC

Отчет

Viva Energy FY Commercial & Industrial Ebitda A$460.5 Million

23 февр. 2026 г., 22:22 UTC

Отчет

Viva Energy FY Convenience & Mobility Ebitda A$197.4 Million

23 февр. 2026 г., 22:22 UTC

Отчет

Viva Energy FY Underlying Ebitda A$700.9 Million

23 февр. 2026 г., 22:22 UTC

Отчет

Viva Energy Final Dividend 3.94 Australian Cents/Security

23 февр. 2026 г., 22:21 UTC

Отчет

Viva Energy FY Revenue A$28.53 Billion, Down 1.1%

23 февр. 2026 г., 22:21 UTC

Отчет

Viva Energy FY Replacement-Cost Net Profit A$183.6 Million, Down 28%

23 февр. 2026 г., 22:20 UTC

Отчет

Viva Energy FY Historical-Cost Net Loss A$421.1 Million

Сравнение c конкурентами

Изменение цены

Neogen Corp Прогноз

Целевая цена

By TipRanks

-5.83% падение

Прогноз на 12 месяцев

Средняя 10.67 USD  -5.83%

Максимум 12 USD

Минимум 10 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Neogen Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

4 ratings

2

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

5.17 / 5.99Поддержка и Сопротивление

Краткосрочная

Strong Bullish Evidence

Среднесрочная

Weak Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

149 / 351Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat